Comparison of Total Tumor Volume, Size and Number of Colorectal Liver Metastases in Prediction of Survival in Patients after Liver Resection
Journal Title: Polish Journal of Surgery - Year 2015, Vol 87, Issue 2
Abstract
Liver is the most common location of the colorectal cancer metastases occurrence. Liver resection is the only curative method of treatment. Unfortunately it is feasible only in 25% of patients with colorectal liver metastases, often because of the extensiveness of the disease. The aim of the study was to evaluate the predictive value of total tumor volume, size and number of colorectal liver metastases in patients treated with right hemihepatectomy. Material and methods. A retrospective analysis was performed in a group of 135 patients with colorectal liver metastases, who were treated with right hemihepatectomy. Total tumor volume was estimated based on the formula (4/3)πr3 . Moreover, the study included an analysis of data on the number and size of tumors, radicality of the resection, time between primary tumor resection and liver resection, pre-operative blood serum concentration of carcinoembryonal antigen (CEA) and carcinoma antigen Ca19-9. The predictive value of the factors was evaluated by applying a Cox proportional hazards model and the area under the ROC curve. Results. The univariate analysis has shown the predictive value of size of the largest tumor (p=0.033; HR=1.065 per each cm) on the overall survival, however no predictive value of number of tumors (p=0.997; HR=1.000) and total tumor volume (p=0.212; HR=1.002) was observed. The multivariate analysis did not confirm the predictive value of the size of the largest tumor (p=0.141; HR=1.056). In the analysis of ROC curves, AUROC for the total tumor volume, the size of the largest tumor and the number of tumors were 0.629, 0.608, 0.520, respectively. Conclusions. Total tumor volume, size and number of liver metastases are not independent risk factors for the worse overall survival of patients with colorectal liver metastases treated with liver resection, therefore increased values of these factors should not be a contraindication for surgical treatment.
Authors and Affiliations
Wacław Hołówko, Michał Grąt, Karolina Maria Wronka, Jan Stypułkowski, Rafał Roszkowski, Paweł Studnicki, Marek Krawczyk
Keywords
Related Articles
- EP ID EP74453
- DOI 10.1515/pjs-2015-0019
- Views 137
- Downloads 0
Kolonoskopia w ramach Programu Badań Przesiewowych raka jelita grubego – czy może być właściwie przeprowadzona przez rezydenta chirurgii ogólnej?
WPROWADZENIE: Kolonoskopia jest uznawana za złoty standard badań przesiewowych w kierunku raka jelita grubego (RJG). Trening endoskopowy jest podstawowym elementem programu specjalizacji w zakresie chirurgii ogólnej. Pac...
Splenic abscess with bleeding in a female patient following coronary artery bypass grafting and cholecystectomy – a case report and literature review
Splenic abscess is a potential complication of many disease entities which involve infections. Diagnostics are based on imaging studies. Treatment involves splenectomy and antibiotic therapy. In the case the abscess is l...
Single-Incision Laparoscopic Cholecystectomy - can we Afford that? Cost Comparison of Different Surgical Techniques
One of the most commonly performed surgeries in general surgery wards with laparoscopic technique as a method of choice is gall-bladder excision. In addition to -the commonly used conventional laparoscopic cholecystectom...
The use of the enhanced recovery after surgery (ERAS) protocol in patients undergoing laparoscopic surgery for colorectal cancer – a comparative analysis of patients aged above 80 and below 55
Age is one of the principal risk factors for colorectal adenocarcinoma. To date, older patients were believed to achieve worse treatment results in comparison with younger patients due to reduced vital capacity. However,...
Związek polimorfizmów XRCC6 C1310G i LIG4 T9I genów naprawy DNA szlaku NHEJ z ryzykiem występowania raka jelita grubego w populacji polskiej
WSTĘP: Rak jelita grubego (RJG) zajmuje na świecie drugie miejsce wśród przyczyn zgonów na nowotwory złośliwe. Utrata integralności genomu spowodowana jest uszkodzeniami DNA generowanymi przy użyciu czynników środowiskow...